Dina Ioffe, MD, on Disparities in HCC: Do They Affect Systemic Care?

January 15, 2026 By The ASCO Post Staff

Dina Ioffe, MD, of Fox Chase Cancer Center, describes the results of an analysis that sought to determine how race/ethnicity, insurance status, and socioeconomic status may affect patterns of systemic treatment for metastatic hepatocellular carcinoma (HCC) (Abstract 489). 

Related Content